✦ LIBER ✦

Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events

✍ Scribed by James M. Scheiman; Clemence E. Hindley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PGI3 RISK OF UPPER GASTROINTESTINAL ADVE

✍ S Johansson; B Farahmand; S Joelson; L Estborn; MA Wallander 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

Treatment Options for Patients with Hepa

✍ Jason P. Smith 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

A Risk Scoring System to Identify Emerge

✍ Stiell, Ian G.; Clement, Catherine M.; Brison, Robert J.; Rowe, Brian H.; Borgun 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Significance of a Multiple Biomarkers St

✍ Toshimitsu Nozaki; Seigo Sugiyama; Hidenobu Koga; Koichi Sugamura; Keisuke Ohba; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 612 KB

A comparison of aspirin and clopidogrel

✍ Fei-Yuan Hsiao; Yi-Wen Tsai; Weng-Foung Huang; Yu-Wen Wen; Pei-Fen Chen; Po-Yin 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Ramipril reduced the risk of cardiovascu

✍ S. Sethu; K. Reddy 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 73 KB